Abstract is: Paul R. Sanberg is an American scientist and inventor. His early work focused on the causes of brain cell death. His recent research has been on methods of repairing damaged brain tissue, and, in tandem with other scientists, demonstrating that stem cells derived from the blood of bone marrow and umbilical cords can be converted to neural cells. Sanberg is a distinguished university professor of medicine, engineering, and business at the University of South Florida. He served as Senior Vice President for Research, Innovation and Knowledge Enterprise from 2012 to 2021. He is also the President and Founder of the National Academy of Inventors.
| human | Q5 |
| P268 | Bibliothèque nationale de France ID | 14589152x |
| P646 | Freebase ID | /m/01370l8n |
| P1960 | Google Scholar author ID | 7dWL3PMAAAAJ |
| P269 | IdRef ID | 067337457 |
| P213 | ISNI | 0000000083508838 |
| P8189 | J9U ID | 987007424238705171 |
| P244 | Library of Congress authority ID | n85334246 |
| P1207 | NUKAT ID | n2007103049 |
| P214 | VIAF cluster ID | 2717538 |
| P166 | award received | Fellow of the Biomedical Engineering Society | Q59767038 |
| P69 | educated at | Australian National University | Q127990 |
| Johns Hopkins University | Q193727 | ||
| University of British Columbia | Q391028 | ||
| York University | Q849751 | ||
| P108 | employer | University of South Florida | Q500606 |
| P734 | family name | Sanberg | Q37541002 |
| P735 | given name | Paul | Q4925623 |
| Paul | Q4925623 | ||
| P106 | occupation | inventor | Q205375 |
| neurologist | Q783906 | ||
| P21 | sex or gender | male | Q6581097 |
| Q92977029 | A 'stroke' of genius: celebrating the 20-year anniversary of the Bernard Sanberg Memorial Award for Brain Repair |
| Q91979168 | A Gutsy Move for Cell-Based Regenerative Medicine in Parkinson's Disease: Targeting the Gut Microbiome to Sequester Inflammation and Neurotoxicity |
| Q47115654 | A New Chapter for Cell Transplantation |
| Q92821431 | A Novel Apolipoprotein E Antagonist Functionally Blocks Apolipoprotein E Interaction With N-terminal Amyloid Precursor Protein, Reduces β-Amyloid-Associated Pathology, and Improves Cognition |
| Q51173678 | A Showcase of Bench-to-Bedside Regenerative Medicine at the 2010 ASNTR |
| Q34522072 | A single administration of human umbilical cord blood T cells produces long-lasting effects in the aging hippocampus |
| Q41868287 | Acute Treatment with Herbal Extracts Provides Neuroprotective Benefits in in Vitro and in vivo Stroke Models, Characterized by Reduced Ischemic Cell Death and Maintenance of Motor and Neurological Functions |
| Q45244049 | Acute functional effects of cyclosporine-A and methylprednisolone treatment in adult rats exposed to transient ischemic stroke |
| Q34358408 | Adult stem cell transplantation: is gender a factor in stemness? |
| Q38062988 | Advantages and challenges of alternative sources of adult-derived stem cells for brain repair in stroke |
| Q41775688 | Alpha-synuclein as a pathological link between chronic traumatic brain injury and Parkinson's disease |
| Q37883632 | Amyotrophic lateral sclerosis: a neurovascular disease. |
| Q30489124 | Announcing a New Open Access Journal: Cell Medicine, Part B of Cell Transplantation |
| Q84009856 | Announcing a new open access Journal Cell Medicine: Cell Transplantation Part B |
| Q34469782 | Anti-inflammatory effects of human cord blood cells in a rat model of stroke |
| Q48676898 | Anxiolytic effects of mecamylamine in two animal models of anxiety |
| Q36940735 | Apigenin and luteolin modulate microglial activation via inhibition of STAT1-induced CD40 expression |
| Q48158385 | Article Commentary: Cell Transplantation: The Regenerative Medicine Journal. A Biennial Analysis of Publications |
| Q37003823 | Article Commentary: Regenerative Medicine: An Analysis of Cell Transplantation's Impact |
| Q95800410 | Article Commentary: Stem Cell Research in Cell Transplantation: An Analysis of Geopolitical Influence by Publications |
| Q38779776 | Autophagic down-regulation in motor neurons remarkably prolongs the survival of ALS mice |
| Q46662805 | Biodistribution of Infused Human Umbilical Cord Blood Cells in Alzheimer's Disease-Like Murine Model. |
| Q27026792 | Blood-CNS Barrier Impairment in ALS patients versus an animal model |
| Q42617884 | Blood-Spinal Cord Barrier Alterations in Subacute and Chronic Stages of a Rat Model of Focal Cerebral Ischemia |
| Q34722888 | Blood-brain barrier alterations provide evidence of subacute diaschisis in an ischemic stroke rat model |
| Q35041986 | Blood-brain barrier impairment in MPS III patients |
| Q37362513 | Blueberry opposes beta-amyloid peptide-induced microglial activation via inhibition of p44/42 mitogen-activation protein kinase |
| Q38259683 | Bone marrow-derived stem cell therapy for metastatic brain cancers |
| Q90025720 | Brazilian Jiu Jitsu Training for US Service Members and Veterans with Symptoms of PTSD |
| Q48901226 | Breaking the Blood-Brain Barrier With Mannitol to Aid Stem Cell Therapeutics in the Chronic Stroke Brain |
| Q53369015 | CD40 signaling regulates innate and adaptive activation of microglia in response to amyloid beta-peptide |
| Q79211514 | Cell Therapy and Homeland Security: Funding Opportunities for Biomedical Research |
| Q34595662 | Cell Therapy from Bench to Bedside Translation in CNS Neurorestoratology Era |
| Q89932395 | Cell Transplantation: New Changes for the End of the Century |
| Q75418302 | Cell Transplantation: The Regenerative Medicine Journal. A biennial analysis of publications |
| Q98611859 | Cell-Free Extracellular Vesicles Derived from Human Bone Marrow Endothelial Progenitor Cells as Potential Therapeutics for Microvascular Endothelium Restoration in ALS |
| Q45042816 | Central nervous system entry of peripherally injected umbilical cord blood cells is not required for neuroprotection in stroke |
| Q44823866 | Cholinergic modulation of microglial activation by alpha 7 nicotinic receptors |
| Q52594563 | Clinical Cell Therapy Guidelines for Neurorestoration (IANR/CANR 2017). |
| Q34409696 | Combination therapy of human umbilical cord blood cells and granulocyte colony stimulating factor reduces histopathological and motor impairments in an experimental model of chronic traumatic brain injury |
| Q33934963 | Compromised blood-brain barrier competence in remote brain areas in ischemic stroke rats at the chronic stage |
| Q38690849 | Cord blood as a potential therapeutic for amyotrophic lateral sclerosis |
| Q48420459 | Cord blood mesenchymal stem cells: Potential use in neurological disorders |
| Q34528569 | Cord blood rescues stroke-induced changes in splenocyte phenotype and function |
| Q45767195 | Correction: Long-Term Upregulation of Inflammation and Suppression of Cell Proliferation in the Brain of Adult Rats Exposed to Traumatic Brain Injury Using the Controlled Cortical Impact Model. |
| Q48520598 | Cytokines produced by cultured human umbilical cord blood (HUCB) cells: implications for brain repair |
| Q46764127 | Dietary supplementation exerts neuroprotective effects in ischemic stroke model. |
| Q33840436 | ESTROGEN REPLACEMENT THERAPY FOR STROKE. |
| Q36241900 | EVALUATION OF HOW CIGARETTE SMOKE IS A DIRECT RISK FACTOR FOR ALZHEIMER'S DISEASE |
| Q44722641 | Effects of Sertoli cell transplants in a 3-nitropropionic acid model of early Huntington's disease: a preliminary study |
| Q34090203 | Effects of blue-green algae extracts on the proliferation of human adult stem cells in vitro: a preliminary study |
| Q48480485 | Effects of middle cerebral artery occlusion on spontaneous activity and cognitive function in rats |
| Q90211323 | Effects of nutraceutical intervention on serum proteins in aged rats |
| Q36490863 | Elusive mechanisms of "stem cell"-mediated repair of cerebral damage |
| Q92317681 | Empathy in stroke rats is modulated by social settings |
| Q38730523 | Endothelial and Astrocytic Support by Human Bone Marrow Stem Cell Grafts into Symptomatic ALS Mice towards Blood-Spinal Cord Barrier Repair |
| Q26775784 | Enhancing endogenous stem cells in the newborn via delayed umbilical cord clamping |
| Q48494714 | Enhancing tyrosine hydroxylase expression and survival of fetal ventral mesencephalon neurons with rat or porcine Sertoli cells in vitro |
| Q35036467 | Epidemiological survey-based formulae to approximate incidence and prevalence of neurological disorders in the United States: a meta-analysis |
| Q48484846 | Evaluation of humoral immune response in adaptive immunity in ALS patients during disease progression |
| Q93049974 | Eye Opener in Stroke |
| Q82973966 | Feasibility of cell therapy for amyotrophic lateral sclerosis |
| Q98396580 | Fighting the War Against COVID-19 via Cell-Based Regenerative Medicine: Lessons Learned from 1918 Spanish Flu and Other Previous Pandemics |
| Q48777797 | From the basics to application of cell therapy, a steppingstone to the conquest of neurodegeneration: a meeting report. |
| Q40717981 | Functional recovery after complete contusion injury to the spinal cord and transplantation of human neuroteratocarcinoma neurons in rats. |
| Q38342285 | G-CSF as an adjunctive therapy with umbilical cord blood cell transplantation for traumatic brain injury |
| Q36251153 | Gene therapy, cell transplantation and stroke. |
| Q90901096 | Gut Microbiome: Lactation, Childbirth, Lung Dysbiosis, Animal Modeling, Stem Cell Treatment, and CNS Disorders |
| Q92425824 | Gutting the brain of inflammation: A key role of gut microbiome in human umbilical cord blood plasma therapy in Parkinson's disease model |
| Q34480228 | Human Umbilical Cord Blood Cells Have Trophic Effects on Young and Aging Hippocampal Neurons in Vitro |
| Q54455328 | Human Umbilical Cord Blood Mononuclear Cell-Conditioned Media Inhibits Hypoxic-Induced Apoptosis in Human Coronary Artery Endothelial Cells and Cardiac Myocytes by Activation of the Survival Protein Akt |
| Q37353891 | Human Umbilical Cord Blood for Transplantation Therapy in Myocardial Infarction |
| Q47245780 | Human cord blood cells and myocardial infarction: effect of dose and route of administration on infarct size |
| Q81031946 | Human cord blood mononuclear cells decrease cytokines and inflammatory cells in acute myocardial infarction |
| Q35625454 | Human umbilical cord blood (HUCB) cells for central nervous system repair |
| Q37517949 | Human umbilical cord blood cell grafts for brain ischemia |
| Q33691302 | Human umbilical cord blood cells decrease microglial survival in vitro |
| Q44035987 | Human umbilical cord blood cells express neural antigens after transplantation into the developing rat brain |
| Q36539637 | Human umbilical cord blood cells induce neuroprotective change in gene expression profile in neurons after ischemia through activation of Akt pathway |
| Q54508747 | Human umbilical cord blood mononuclear cells activate the survival protein Akt in cardiac myocytes and endothelial cells that limits apoptosis and necrosis during hypoxia |
| Q81360936 | Human umbilical cord blood mononuclear cells for the treatment of acute myocardial infarction |
| Q47309435 | Human umbilical cord blood progenitor cells are attracted to infarcted myocardium and significantly reduce myocardial infarction size |
| Q42026710 | Human umbilical cord blood progenitors: the potential of these hematopoietic cells to become neural |
| Q48255226 | Human umbilical cord blood stem cells infusion in spinal cord injury: engraftment and beneficial influence on behavior |
| Q33346297 | Human umbilical cord blood treatment in a mouse model of ALS: optimization of cell dose |
| Q50574806 | Human umbilical cord blood-derived monocytes improve cognitive deficits and reduce amyloid-β pathology in PSAPP mice. |
| Q35806256 | Humoral factors in ALS patients during disease progression. |
| Q28069948 | Hyperbaric oxygen therapy as a potential treatment for post-traumatic stress disorder associated with traumatic brain injury |
| Q38170060 | Immunological aspects in amyotrophic lateral sclerosis |
| Q91843996 | Immunomodulation with Human Umbilical Cord Blood Stem Cells Ameliorates Ischemic Brain Injury - A Brain Transcriptome Profiling Analysis |
| Q48454562 | Impaired blood-brain/spinal cord barrier in ALS patients |
| Q49111515 | Implications of blood-brain barrier disruption in ALS. |
| Q33834046 | Increased Amyloid Precursor Protein and Tau Expression Manifests as Key Secondary Cell Death in Chronic Traumatic Brain Injury |
| Q39830632 | Increased neuronal proliferation in the dentate gyrus of aged rats following neural stem cell implantation. |
| Q37387232 | Inflammation and stem cell migration to the injured brain in higher organisms |
| Q35069671 | Influence of post-traumatic stress disorder on neuroinflammation and cell proliferation in a rat model of traumatic brain injury |
| Q45025359 | Infusion of human umbilical cord blood cells in a rat model of stroke dose-dependently rescues behavioral deficits and reduces infarct volume |
| Q44510907 | Intravenous administration of human umbilical cord blood cells in a mouse model of amyotrophic lateral sclerosis: distribution, migration, and differentiation |
| Q47926676 | Intravenous administration of human umbilical cord blood cells in an animal model of MPS III B. |
| Q30710096 | Intravenous administration of human umbilical cord blood reduces neurological deficit in the rat after traumatic brain injury. |
| Q40682303 | Lithium exposure enhances survival of NT2N cells (hNT neurons) in the hemiparkinsonian rat. |
| Q102065227 | LncRNAs Stand as Potent Biomarkers and Therapeutic Targets for Stroke |
| Q37186930 | Long-term cultured human umbilical cord neural-like cells transplanted into the striatum of NOD SCID mice. |
| Q27321727 | Long-term upregulation of inflammation and suppression of cell proliferation in the brain of adult rats exposed to traumatic brain injury using the controlled cortical impact model |
| Q45066194 | Lovastatin modulation of microglial activation via suppression of functional CD40 expression |
| Q82079204 | Lymphopenia and spontaneous autorosette formation in SOD1 mouse model of ALS |
| Q89918624 | MICROTRANSPLANTATION OF NIGRAL DOPAMINE NEURONS IN A RAT MODEL OF PARKINSON'S DISEASE |
| Q81260276 | MIP-1alpha and MCP-1 Induce Migration of Human Umbilical Cord Blood Cells in Models of Stroke |
| Q37296284 | Mankind's first natural stem cell transplant. |
| Q33852356 | Mannitol-enhanced delivery of stem cells and their growth factors across the blood-brain barrier |
| Q82213972 | Maternal transplantation of human umbilical cord blood cells provides prenatal therapy in Sanfilippo type B mouse model |
| Q58096116 | May the force be with you: Transfer of healthy mitochondria from stem cells to stroke cells |
| Q35171618 | Menstrual blood cells display stem cell-like phenotypic markers and exert neuroprotection following transplantation in experimental stroke. |
| Q34253171 | Menstrual blood transplantation for ischemic stroke: Therapeutic mechanisms and practical issues. |
| Q35978608 | Mesenchymal stem cells in autoimmune disease |
| Q33442279 | Methodological study investigating long term laser Doppler measured cerebral blood flow changes in a permanently occluded rat stroke model |
| Q48229759 | Mobilized peripheral blood cells administered intravenously produce functional recovery in stroke |
| Q37296292 | Monocyte transplantation for neural and cardiovascular ischemia repair |
| Q52552931 | Mouse model of Sanfilippo syndrome type B: relation of phenotypic features to background strain. |
| Q28732245 | Multiple Intravenous Administrations of Human Umbilical Cord Blood Cells Benefit in a Mouse Model of ALS |
| Q36547428 | Multiple Low-Dose Infusions of Human Umbilical Cord Blood Cells Improve Cognitive Impairments and Reduce Amyloid-β-Associated Neuropathology in Alzheimer Mice |
| Q40204164 | Multiple transplants of hNT cells into the spinal cord of SOD1 mouse model of familial amyotrophic lateral sclerosis |
| Q37402866 | Navigating cellular repair for the central nervous system |
| Q36340481 | Nestin overexpression precedes caspase-3 upregulation in rats exposed to controlled cortical impact traumatic brain injury |
| Q83218237 | Neural specification of stem cell differentiation |
| Q34731427 | Neural transplantation for treatment of Parkinson's disease. |
| Q34995032 | Neural transplantation in the new millenium |
| Q48678244 | Neurodegeneration in the rat hippocampus and striatum after middle cerebral artery occlusion |
| Q26830211 | Neurological disorders and the potential role for stem cells as a therapy |
| Q48454295 | Neuronal nicotinic receptor inhibition for treating mood disorders: preliminary controlled evidence with mecamylamine |
| Q38022886 | Neurovascular aspects of amyotrophic lateral sclerosis. |
| Q34959810 | Nicotine's oxidative and antioxidant properties in CNS. |
| Q40692719 | Nicotinic acetylcholine receptors on NT2 precursor cells and hNT (NT2-N) neurons |
| Q36626146 | Novel cell therapy approaches for brain repair |
| Q33720062 | Nutraceutical intervention improves older adults' cognitive functioning |
| Q40981496 | Nutraceutical intervention reverses the negative effects of blood from aged rats on stem cells. |
| Q46979290 | Nutraceuticals synergistically promote proliferation of human stem cells |
| Q41812779 | Oligodendrocytes engineered with migratory proteins as effective graft source for cell transplantation in multiple sclerosis |
| Q53974443 | Online Manuscript Processing for Cell Transplantation |
| Q34631904 | Optimized Turmeric Extract Reduces ?-Amyloid and Phosphorylated Tau Protein Burden in Alzheimer's Transgenic Mice |
| Q39806779 | Optimized turmeric extracts have potent anti-amyloidogenic effects |
| Q50767344 | Ovarian monocyte progenitor cells: phenotypic and functional characterization |
| Q48159883 | Oxidative stress of neural, hematopoietic, and stem cells: protection by natural compounds. |
| Q33319902 | Peripheral injection of human umbilical cord blood stimulates neurogenesis in the aged rat brain |
| Q37113500 | Peripherally administered human umbilical cord blood cells reduce parenchymal and vascular beta-amyloid deposits in Alzheimer mice |
| Q93165682 | Phenotypic characteristics of human bone marrow-derived endothelial progenitor cells in vitro support cell effectiveness for repair of the blood-spinal cord barrier in ALS |
| Q48088113 | Plasma Derived From Human Umbilical Cord Blood Modulates Mitogen-Induced Proliferation of Mononuclear Cells Isolated From the Peripheral Blood of ALS Patients. |
| Q41888671 | Plasma and Brain Pharmacokinetics of Previously Unexplored Lithium Salts |
| Q58597983 | Plasma derived from human umbilical cord blood: Potential cell-additive or cell-substitute therapeutic for neurodegenerative diseases |
| Q40741347 | Positive effect of transplantation of hNT neurons (NTera 2/D1 cell-line) in a model of familial amyotrophic lateral sclerosis |
| Q47829271 | Potential Role of Humoral IL-6 Cytokine in Mediating Pro-Inflammatory Endothelial Cell Response in Amyotrophic Lateral Sclerosis. |
| Q38881707 | Potential new complication in drug therapy development for amyotrophic lateral sclerosis |
| Q48269383 | Preliminary study of the behavioral effects of LBS-neuron implantation on seizure susceptibility following middle cerebral artery occlusion in the rats |
| Q60949528 | Progress and Updates in Stroke Research: Introduction to the Special Issue on Stroke |
| Q47739912 | Quantitative analyses of matrix metalloproteinase activity after traumatic brain injury in adult rats |
| Q35040792 | Recent Studies Assessing the Proliferative Capability of a Novel Adult Stem Cell Identified in Menstrual Blood |
| Q37885486 | Recent progress in cell therapy for basal ganglia disorders with emphasis on menstrual blood transplantation in stroke. |
| Q48482314 | Reduced Nuclear Factor kappa B activation in dentate gyrus after active avoidance training |
| Q28752226 | Reduction of circulating endothelial cells in peripheral blood of ALS patients |
| Q51740533 | Reduction of microhemorrhages in the spinal cord of symptomatic ALS mice after intravenous human bone marrow stem cell transplantation accompanies repair of the blood-spinal cord barrier |
| Q51143014 | Regenerative medicine for neurological disorders |
| Q95816727 | Regenerative medicine: an analysis of Cell Transplantation's impact |
| Q42635494 | Repeated Administrations of Human Umbilical Cord Blood Cells Improve Disease Outcomes in a Mouse Model of Sanfilippo Syndrome Type III B. |
| Q41614431 | Repeated administrations of human umbilical cord blood cells improve disease outcomes in a mouse model of Sanfilippo syndrome type III B. |
| Q92332744 | Retrospective Case Series of Traumatic Brain Injury and Post-Traumatic Stress Disorder Treated with Hyperbaric Oxygen Therapy |
| Q48631906 | Routes of stem cell administration in the adult rodent |
| Q80965707 | Routes of stem cell administration in the adult rodent |
| Q45941962 | Severity of controlled cortical impact traumatic brain injury in rats and mice dictates degree of behavioral deficits. |
| Q28752354 | Spirulina promotes stem cell genesis and protects against LPS induced declines in neural stem cell proliferation |
| Q37297118 | Stem Cell Research and Health Education |
| Q53254391 | Stem cell research in Cell Transplantation: an analysis of geopolitical influence by publications |
| Q44329785 | Stem cell research in cell transplantation: sources, geopolitical influence, and transplantation |
| Q37658508 | Stem cell transplants at childbirth. |
| Q37795541 | Stem cells have the potential to rejuvenate regenerative medicine research |
| Q36718500 | Stem cells in cell transplantation |
| Q47606611 | Stem cells: shibboleths of development, part II: Toward a functional definition |
| Q81524557 | Stroke-induced migration of human umbilical cord blood cells: time course and cytokines |
| Q88715371 | Suppressed acoustic startle response in traumatic brain injury masks post-traumatic stress disorder hyper-responsivity |
| Q37955707 | Technology and innovation: 2010 a year in review |
| Q98719473 | The Disillusioned Comfort with COVID-19 and the Potential of Convalescent Plasma and Cell Therapy |
| Q42948657 | The Effect of Human Umbilical Cord Blood Cells on Survival and Cytokine Production by Post-Ischemic Astrocytes in Vitro |
| Q37778767 | The Proliferation and Differentiation of Stem Cell Journals |
| Q79076950 | The Tourette's Disorder Scale (TODS): development, reliability, and validity |
| Q37312997 | The emerging field of cell and tissue engineering. |
| Q38030975 | The immunology of traumatic brain injury: a prime target for Alzheimer's disease prevention. |
| Q38155690 | The innate and adaptive immunological aspects in neurodegenerative diseases |
| Q37181491 | The neuroscientist's melting pot: immunology, cell transplantation and other delivery systems, and enlightenment of disease etiology and treatment |
| Q38221442 | The potential of neural stem cell transplantation for the treatment of fetal alcohol spectrum disorder |
| Q34410713 | The role of tau protein in HIV-associated neurocognitive disorders |
| Q44602739 | The transcription factor Nurr1 in human NT2 cells and hNT neurons |
| Q37795969 | The treatment of neurodegenerative disorders using umbilical cord blood and menstrual blood-derived stem cells. |
| Q48526513 | Timing of cord blood treatment after experimental stroke determines therapeutic efficacy |
| Q35581959 | Toward personalized cell therapies: autologous menstrual blood cells for stroke. |
| Q48792769 | Transplantation of human umbilical cord blood cells benefits an animal model of Sanfilippo syndrome type B. |
| Q35681487 | Transplantation of human umbilical cord blood cells in the repair of CNS diseases |
| Q37763613 | Transplantation of umbilical cord blood stem cells for treating spinal cord injury |
| Q37186924 | Trophic factor induction of human umbilical cord blood cells in vitro and in vivo |
| Q36051656 | Tumorigenicity issues of embryonic carcinoma-derived stem cells: relevance to surgical trials using NT2 and hNT neural cells |
| Q48583625 | Umbilical cord blood cell and granulocyte-colony stimulating factor: combination therapy for traumatic brain injury |
| Q48654055 | Umbilical cord blood cells |
| Q36808858 | Umbilical cord blood research: current and future perspectives |
| Q40192959 | Umbilical cord blood transfusions for prevention of progressive brain injury and induction of neural recovery: an immunological perspective |
| Q36167454 | Umbilical cord blood-derived stem cells and brain repair. |
| Q47146732 | Updates on and Advances in Therapeutic Strategies for Traumatic Brain Injury |
| Q36266128 | Use of human umbilical cord blood (HUCB) cells to repair the damaged brain |
| Q105352816 | Motor Activity and Movement Disorders | editor | P98 |
| Paul R. Sanberg | wikipedia |
Search more.